| Stage | PSMT | % of rev | ALG | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $451M | 100.00% | PSMT ×3.36 |
| Gross profit | $267M | 17.60% | $111M | 24.59% | ALG +7.0pp |
| Operating income | $57M | 3.76% | $46M | 10.15% | ALG +6.4pp |
| Pre-tax income | $50M | 3.31% | $42M | 9.23% | ALG +5.9pp |
| Net income | $38M | 2.48% | $31M | 6.86% | ALG +4.4pp |
| Stage | PSMT | ALG | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $451M100.00% | PSMT ×3.36 |
| Gross profit | 17.60%$267M | 24.59%$111M | ALG +7.0pp |
| Operating income | 3.76%$57M | 10.15%$46M | ALG +6.4pp |
| Pre-tax income | 3.31%$50M | 9.23%$42M | ALG +5.9pp |
| Net income |
| 2.48%$38M |
| 6.86%$31M |
| ALG +4.4pp |
No disclosed counterparties: ALG.
None